Comparison

Tusamitamab Ravtansine Biosimilar - Research Grade European Partner

Item no. ICH5040R-0.1mg
Manufacturer IchorBio
Amount 0.1 mg
Quantity options 0.1 mg 1 mg
Category
Format Liquid
Applications FA
Specific against Human (Homo sapiens)
Host CHO cells
Isotype IgG1
Purity >90% by SDS-PAGE
Alias DM4
Shipping Condition Room temperature
Available
Manufacturer - Category
Biosimilar, Low endotoxin, recombinant antibody, antibody drug conjugate (ADC)
Manufacturer - Targets
CEACAM5 / CEA / CD66e
Shipping Temperature
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Application Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
Background
Tusamitamab ravtansine is a novel antibody-drug conjugate that selectively targets CEACAM5, a cell surface glycoprotein highly expressed in several tumor types. Tusamitamab ravtansine showed promising antitumor activity in patients (pts) with heavily pretreated NSQ NSCLC and high CEACAM5 expression.
Concentration
1mg/ml
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close